Growth Stock Portfolio: 15 Companies with At Least 30% Annual Growth Rates

In this article, we will take a look at the 15 stocks with at least 30% annual growth rates to consider for a growth stock portfolio. To skip our analysis of recent market trends, you can go directly to Growth Stock Portfolio: 5 Companies with At Least 30% Annual Growth Rates. As the stock market […]

Related Keywords

Australia ,United States ,Shanghai ,China ,California ,San Francisco ,San Diego ,New York ,Brooklyn ,Timessquare ,Chinese ,Australian ,American ,Daniel Patrick Gibson ,Ellis Unger ,Cathie Wood ,Robert Califf ,Brian Bares ,Al Gore ,Jim Mckelvey ,Jack Dorsey ,Alexandra Steiger ,Patrick Walravens ,Emster Venbio ,Tesla Inc ,Neurocrine Biosciences Inc ,Draftkings Inc ,Block Inc ,Office Of Drug Evaluation ,Twilio Inc ,Square Inc ,Harding Loevner Global Small Companies Equity Strategy ,Australian Therapeutic Goods Administration ,Shopify Inc ,Health Care ,Sarepta Therapeutics Inc ,Nasdaq ,Baron Global Advantage Fund ,Holdings Inc ,Information Technology ,Baron Fintech Fund ,Morgan Stanley ,European Medicines Agency ,Bronte Capital Amalthea Fund ,Coinbase Global Inc ,Devices Inc ,Mercadolibre Inc ,Number Of Hedge Fund Holders ,Generation Investment Management ,Goldman Sachs ,Etsy Inc ,Year Annual Sales Growth ,Hedge Fund Holders ,Coinbase Global ,Insider Monkey ,Advanced Micro Devices ,Bares Capital Management ,Capital Management ,Cap Growth Strategy ,Market Outperform ,David Blood ,Kurt Von Emster ,Venbio Select Advisor ,Capital Amalthea Fund ,Sarepta Therapeutics ,Federal Food ,Drug Evaluation ,California Based Neurocrine Biosciences ,Neurocrine Biosciences ,Steve Cohen ,Loevner Global Small Companies Equity Strategy ,Andreas Halvorsen ,Viking Global ,Cash App ,Lei Zhang ,Hillhouse Capital Management ,Nc ,Mercadolibre ,Hedge Fund ,Tesla ,Annual Growth ,Growth Stock ,